Ignite Creation Date:
2024-05-06 @ 2:26 PM
Last Modification Date:
2024-10-26 @ 1:31 PM
Study NCT ID:
NCT04329429
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-12-20
First Post:
2020-03-27
Brief Title:
A Study of RC48-ADC in Subjects With HER2 Overexpressed Metastatic Biliary Tract Cancer
Sponsor:
RemeGen Co Ltd
Organization:
RemeGen Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-08-24
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-03-27
First Submit QC Date:
March 31 2020
Study First Post Date:
2020-04-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-14
Last Update Post Date:
2023-12-20
Last Update Post Date Type:
ACTUAL